These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 27697776)

  • 1. AACR Cancer Progress Report 2016.
    Davidson NE; Armstrong SA; Coussens LM; Cruz-Correa MR; DeBerardinis RJ; Doroshow JH; Foti M; Hwu P; Kensler TW; Morrow M; Mulligan CG; Pao W; Platz EA; Smith TJ; Willman CL
    Clin Cancer Res; 2016 Oct; 22 Suppl 19():S1-S137. PubMed ID: 27697776
    [No Abstract]   [Full Text] [Related]  

  • 2. [New treatments in immuno-oncology: a revolution and a formidable scientific and clinical challenge].
    Champiat S; Soria JC
    Med Sci (Paris); 2017; 33(6-7):563-564. PubMed ID: 28990546
    [No Abstract]   [Full Text] [Related]  

  • 3. AACR Cancer Progress Report 2012.
    Cantley LC; Dalton WS; DuBois RN; Finn OJ; Futreal PA; Golub TR; Hait WN; Lozano G; Maris JM; Nelson WG; Sawyers CL; Schreiber SL; Spitz MR; Steeg PS
    Clin Cancer Res; 2012 Nov; 18(21 Suppl):S1-100. PubMed ID: 22977188
    [No Abstract]   [Full Text] [Related]  

  • 4. Cancer treatment of today in view of the Nobel Prize.
    Ullenhag G
    Ups J Med Sci; 2018 Dec; 123(4):205-206. PubMed ID: 30526172
    [No Abstract]   [Full Text] [Related]  

  • 5. From New directions in immuno-oncology.
    Romero D
    Nat Rev Clin Oncol; 2019 Nov; 16(11):660. PubMed ID: 31541198
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical development of immuno-oncology in China.
    Wu DW; Huang HY; Tang Y; Zhao Y; Yang ZM; Wang J; Wang SH; Yu Y; Fang Y; Fang H; Bai Y; Sun C; Fan Q; Yu AQ; Wang HL; Du CX; Chen K; Huang MD; Zhang Y; Li N; Xu BH; Sun Y; He J
    Lancet Oncol; 2020 Aug; 21(8):1013-1016. PubMed ID: 32758460
    [No Abstract]   [Full Text] [Related]  

  • 7.
    Sengupta R; Honey K
    Clin Cancer Res; 2018 Sep; 24(18):4351. PubMed ID: 30209160
    [No Abstract]   [Full Text] [Related]  

  • 8. AACR Cancer Progress Report 2013.
    ; Sawyers CL; Abate-Shen C; Anderson KC; Barker A; Baselga J; Berger NA; Foti M; Jemal A; Lawrence TS; Li CI; Mardis ER; Neumann PJ; Pardoll DM; Prendergast GC; Reed JC; Weiner GJ
    Clin Cancer Res; 2013 Oct; 19(20 Suppl):S4-98. PubMed ID: 24045178
    [No Abstract]   [Full Text] [Related]  

  • 9. Introduction.
    Reardon DA; Weller M
    Neuro Oncol; 2015 Nov; 17 Suppl 7(Suppl 7):vii1. PubMed ID: 26516220
    [No Abstract]   [Full Text] [Related]  

  • 10. Customer pyramid framework for CAR T-cell therapies in immuno-oncology.
    Malik NN; Durdy MB
    Drug Discov Today; 2016 Oct; 21(10):1563-1565. PubMed ID: 27640934
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical Cancer Advances 2009: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
    Petrelli NJ; Winer EP; Brahmer J; Dubey S; Smith S; Thomas C; Vahdat LT; Obel J; Vogelzang N; Markman M; Sweetenham JW; Pfister D; Kris MG; Schuchter LM; Sawaya R; Raghavan D; Ganz PA; Kramer B
    J Clin Oncol; 2009 Dec; 27(35):6052-69. PubMed ID: 19901123
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical cancer advances 2012: annual report on progress against cancer from the american society of clinical oncology.
    Roth BJ; Krilov L; Adams S; Aghajanian CA; Bach P; Braiteh F; Brose MS; Ellis LM; Erba H; George DJ; Gilbert MR; Jacobson JO; Larsen EC; Lichtman SM; Partridge AH; Patel JD; Quinn DI; Robison LL; von Roenn JH; Samlowski W; Schwartz GK; Vogelzang NJ
    J Clin Oncol; 2013 Jan; 31(1):131-61. PubMed ID: 23213095
    [No Abstract]   [Full Text] [Related]  

  • 13. Immuno-Oncology in China.
    Lu S; Chabner BA
    Oncologist; 2019 Feb; 24(Suppl 1):S1-S2. PubMed ID: 30819825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New immunological concepts in oncology].
    Versicherungsmedizin; 2013 Sep; 65(3):156-7. PubMed ID: 24137899
    [No Abstract]   [Full Text] [Related]  

  • 15. Trends in the global immuno-oncology landscape.
    Tang J; Pearce L; O'Donnell-Tormey J; Hubbard-Lucey VM
    Nat Rev Drug Discov; 2018 Nov; 17(11):783-784. PubMed ID: 30337722
    [No Abstract]   [Full Text] [Related]  

  • 16. Future shock: embracing disruption in the immunotherapy revolution.
    Alvarnas J
    Am J Manag Care; 2018 Feb; 24(2 Spec No.):SP34. PubMed ID: 29689140
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical Cancer Advances 2013: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
    Patel JD; Krilov L; Adams S; Aghajanian C; Basch E; Brose MS; Carroll WL; de Lima M; Gilbert MR; Kris MG; Marshall JL; Masters GA; O'Day SJ; Polite B; Schwartz GK; Sharma S; Thompson I; Vogelzang NJ; Roth BJ
    J Clin Oncol; 2014 Jan; 32(2):129-60. PubMed ID: 24327669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Advances in medical oncology].
    Shi YK
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):305-10. PubMed ID: 16900620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Oncology 1999: advances in immunotherapy].
    Cerny T
    Schweiz Med Wochenschr; 2000 Jan; 130(1-2):21-4. PubMed ID: 10670041
    [No Abstract]   [Full Text] [Related]  

  • 20. The New Frontiers in Cancer.
    Batista A
    Trends Cancer; 2016 Oct; 2(10):533. PubMed ID: 28741481
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.